Vaccine hoarding may backfire on rich nations as India reels indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Manufacturing hurdles, not IP, slowing Covid jabs rollout: industry
Health
File photo
GENEVA: Removing intellectual property protections from Covid-19 vaccines or pressuring companies into technology sharing will not speed up production of the jabs, and could even slow it down, the industry has warned.
Proponents of doing away with IP rights say more companies in more countries could produce the vaccines, providing broader access in poorer nations that so far have seen few doses.
South African President Cyril Ramaphosa, whose country is co-leading a push at the World Trade Organization to exempt Covid-19 vaccines from IP rights, insisted Friday the jabs were a public good and must be recognised as such .
Manufacturing hurdles, not IP, slowing Covid jabs rollout: industry
128
GENEVA, April 24, 2021 (BSS/AFP) – Removing intellectual property protections from Covid-19 vaccines or pressuring companies into technology sharing will not speed up production of the jabs, and could even slow it down, the industry has warned.
Proponents of doing away with IP rights say more companies in more countries could produce the vaccines, providing broader access in poorer nations that so far have seen few doses.
South African President Cyril Ramaphosa, whose country is co-leading a push at the World Trade Organization to exempt Covid-19 vaccines from IP rights, insisted Friday the jabs were “a public good and must be recognised as such”.
Health industry blames manufacturing hurdles for slow COVID jabs rollout
By
Saturday Apr 24, 2021
Health workers administer Johnson & Johnson s coronavirus disease (COVID-19) vaccines at a vaccination centre in Ronda, Spain, April 23, 2021. Photo: Reuters
GENEVA: Health industry has laid the blame on manufacturing hurdles over a slow vaccine rollout rather than intellectual property protections placed by the companies.
Proponents of doing away with IP rights say more companies in more countries could produce the vaccines, providing broader access in poorer nations that so far have seen few doses.
South African President Cyril Ramaphosa, whose country is co-leading a push at the World Trade Organisation to exempt COVID-19 vaccines from IP rights, insisted on Friday the jabs were a public good and must be recognised as such .
Geneva: Removing intellectual property (IP) protections from COVID-19 vaccines or pressuring companies into technology sharing will not speed up production of the jabs, and could even slow it down, the industry has warned.
Proponents of doing away with IP rights say more companies in more countries could produce the vaccines, providing broader access in poorer nations that so far have seen few doses.
South African President Cyril Ramaphosa, whose country is co-leading a push at the World Trade Organization to exempt COVID-19 vaccines from IP rights, insisted Friday the jabs were a public good and must be recognised as such .